Granulocyte colony-stimulating factor: preclinical and clinical studies
- PMID: 2483722
Granulocyte colony-stimulating factor: preclinical and clinical studies
Abstract
The production of neutrophil granulocytes is a complex and dynamic process during which a small number of self-renewing stem cells give rise to lineage-specific progenitors. One hematopoietic glycoprotein that appears to specifically control the survival, cycle activation, proliferation and terminal maturation of this myeloid lineage is granulocyte colony-stimulating factor (G-CSF). Some topics discussed are its molecular characterization, biochemical purification, sources, and effects of administration.
Similar articles
-
Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.Nouv Rev Fr Hematol (1978). 1989;31(2):99-101. Nouv Rev Fr Hematol (1978). 1989. PMID: 2475852 Review. No abstract available.
-
Clinical role of granulocyte-macrophage colony-stimulating factor.Hematol Oncol Clin North Am. 1989 Sep;3(3):411-25. Hematol Oncol Clin North Am. 1989. PMID: 2698875 Review.
-
Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression.Int J Cell Cloning. 1990 Mar;8(2):107-22. doi: 10.1002/stem.5530080204. Int J Cell Cloning. 1990. PMID: 1690250
-
[GM-CSF: its use in onco-hematologic diseases].Haematologica. 1989 Oct;74(5 Suppl):501-10. Haematologica. 1989. PMID: 2512232 Review. Italian. No abstract available.
-
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis.Blood Cells. 1987;13(1-2):17-30. Blood Cells. 1987. PMID: 3311216
Cited by
-
Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistance against Listeria monocytogenes.Immunology. 1992 Mar;75(3):475-80. Immunology. 1992. PMID: 1374055 Free PMC article.
-
Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.Jpn J Cancer Res. 1990 Nov;81(11):1168-74. doi: 10.1111/j.1349-7006.1990.tb02530.x. Jpn J Cancer Res. 1990. PMID: 1702415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical